Detail akcie Shionogi & Co online

Business Summary: Shionogi & Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the research and development, purchasing, manufacturing, sales, and related activities of ethical pharmaceuticals. The Company is engaged in research and development, purchasing, manufacturing, and marketing of pharmaceuticals for the treatment of gram-negative bacterial infections, influenza virus infections, new coronavirus infections, invasive aspergillus infections, complicated urinary tract infections including pyelonephritis, Alzheimer's disease, chronic pain, cancer of the esophagus, bladder, head and neck, solid tumors, and other diseases. The Company provides products and services in Japan, Europe, North America, and other regions.
Financial Summary: BRIEF: For the nine months ended 31 December 2024, Shionogi & Co Ltd revenues decreased 1% to Y333.6B. Net income applicable to common stockholders increased 5% to Y133.8B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Other expenses decrease of 68% to Y2.95B (expense), Finance income increase of 3% to Y33.01B (income), Other income increase of 40% to Y501M (income).